Investigating receptor enzyme activity using time-scale analysis.

Area of Science:

• Pharmacology and Drug Discovery
• Biochemistry and Molecular Biology
• Computational Chemistry and Cheminformatics

Background:

• Early drug discovery relies on protein-based assays to determine compound potency.
• Dose-response characterization often assumes time-independent inhibition implies reversibility and time-dependent inhibition implies irreversibility.

Purpose of the Study:

• To investigate the validity of the assumption linking time-independent inhibition to reversibility.
• To explore how receptor synthesis and degradation influence drug inhibition in cell-based assays.

Main Methods:

• Development and analysis of a simple kinetics model for drug-receptor interactions.
• Utilizing model-based analytical solutions and numerical simulations to study dose-response behavior.
• Incorporating receptor synthesis and degradation dynamics into in vitro cell-based assay models.

Main Results:

• Model-based analysis demonstrates that irreversible inhibitors can exhibit time-independent dose-response under specific conditions.
• The synthesis and degradation of target receptors can also cause irreversible inhibitors to appear time-independent in cell-based assays.
• Steady-state analysis highlights the intricate nature of drug-receptor binding and inhibition processes.

Conclusions:

• Time-independence in dose-response curves is not sufficient evidence to conclude inhibitor reversibility.
• Receptor dynamics significantly impact observed drug inhibition, complicating the interpretation of assay results.
• A deeper kinetic understanding is crucial for accurate characterization of drug-receptor interactions in early drug discovery.